Scopio peripheral blood smear analyzer gets FDA approval

[deleted1074676]

Advertisement - Members don't see this ad

The Full Field PBS utilizes adaptive monolayer identification in support of long and short smears and automates the analysis process by pre-classifying 200 white blood cells (WBC), providing platelet pre-estimate, and enabling RBC morphology evaluation.

Scopio Labs Receives FDA Clearance for its AI-Powered Full Field Peripheral Blood Smear (Full Field PBS) Application

/PRNewswire/ -- Scopio Labs, a leading provider of Full Field Morphology (FFM), announced today that it was granted FDA clearance to market and sell its X100...

www.prnewswire.com

 

[chooks]

So.....Cellavision?

 

[deleted1074676]

In a more perfect world:

1. Cellavision would have been named Diff-Quik
2. Diff-Quik would have been named Cellavision

Anyone agree?

 

[deleted314957]

Is this supposed to eliminate manual diffs or mandatory slide review if set parameters are not met?

 

[deleted1074676]

Is this supposed to eliminate manual diffs or mandatory slide review if set parameters are not met?

Not sure. I think it is suppose to help perform the manual diff... but not sure what "help" really means to a hematopathologist.

 

[Med Director New England]

this technology and similar technologies takes a traditional blood smear and digitizes the smear with oil immersion scope / camera and highlights cells for review by the MTs on a computer screen. So a lot of proprietary hardware in addition to software needed.

has potential to permit manual cell counts in some cases to be performed digitally by MTs (kinda like the thinprep imager for paps). But manual reviews with MT eyes at the scope and reviews by MDs at the scope still happens with any important findings.

 

[deleted314957]

Doesn’t sound earth-shakingly better than the flow cyto metric based method we used in my practice days. And i bet it is big $$$.